Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsisGeorg F. Weber, Filip K. Świrski, Benjamin G. Chousterman et al.|Science|2015Cited by 347
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trialStefan Hagel, Hicham Chkirni, Alexander Brinkmann et al.|Intensive Care Medicine|2022Cited by 171